Francisco, Mercedita T.
HRN: 08-04-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2023
CLINDAMYCIN 300MG (CAP)
05/24/2023
05/30/2023
PO
300mg
QID
UTI, Post Partum Hemorrhage
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes